<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>IHE &mdash; FDA: regulation | Trader Notes</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Lato', -apple-system, sans-serif; background: #FFF1E5; color: #1a1a2e; line-height: 1.6; }
        .container { max-width: 760px; margin: 0 auto; padding: 1.5rem; }
        a { color: #0d7680; }
    </style>
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@700&family=Lato:wght@300;400;700&display=swap" rel="stylesheet">
</head>
<body>
<div class="container">
    <div style="margin-bottom:1rem">
        <a href="../" style="font-size:0.8rem;color:#6b7280;text-decoration:none">&larr; Back to Trading Sheet</a>
    </div>

    <div style="display:flex;align-items:center;gap:12px;margin-bottom:0.5rem;flex-wrap:wrap">
        <span style="font-family:'Playfair Display',serif;font-size:1.8rem;font-weight:700">IHE</span>
        <span style="font-size:0.8rem;padding:4px 12px;border-radius:12px;color:#6b7280;background:#f1f5f9;font-weight:700">WATCHING</span>
        <span style="font-size:0.85rem;color:#6b7280">SHORT 49% &middot; Band C</span>
    </div>
    <div style="font-size:1rem;color:#4b5563;margin-bottom:0.5rem">FDA: regulation</div>

    <div style="display:flex;gap:1.5rem;flex-wrap:wrap;margin:1rem 0"><div><div style="font-size:0.7rem;color:#6b7280;text-transform:uppercase">DD Price</div><div style="font-weight:700;font-size:1.1rem">$90.38</div></div><div><div style="font-size:0.7rem;color:#6b7280;text-transform:uppercase">Current</div><div style="font-weight:700;font-size:1.1rem">$90.38</div></div><div><div style="font-size:0.7rem;color:#7c3aed;text-transform:uppercase">Report P&amp;L</div><div style="font-weight:700;font-size:1.1rem;color:#7c3aed">+0.0%</div></div></div>
    <div style="margin:0.5rem 0"><span style="display:inline-block;padding:3px 10px;border-radius:12px;font-size:0.75rem;font-weight:700;color:#166534;background:#dcfce7">INTACT</span> <span style="display:inline-block;padding:3px 10px;border-radius:12px;font-size:0.75rem;font-weight:700;color:#92400e;background:#fef3c7">&#128264; stirring (2)</span></div>
    <div style="margin:1rem 0">
                <div style="font-size:0.75rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:4px">Conviction</div>
                <div style="display:flex;align-items:center;gap:10px">
                    <div style="flex:1;max-width:200px;height:8px;background:#e5e7eb;border-radius:4px;overflow:hidden">
                        <div style="width:60%;height:100%;background:#f59e0b;border-radius:4px"></div>
                    </div>
                    <span style="color:#f59e0b;font-weight:700;font-size:1.1rem">6/10</span>
                </div>
            </div>
    <div style="background:#f9fafb;border-radius:6px;padding:0.8rem 1rem;margin:0.8rem 0;font-size:0.85rem;color:#374151;border-left:3px solid #6b7280"><strong>Status:</strong> DD approved — watching for signal confirmation</div>
    <div style="margin:1rem 0;padding:1rem;background:#fefce8;border-radius:6px;border-left:3px solid #eab308"><div style="font-size:0.75rem;color:#92400e;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:6px">Original Report Thesis</div><div style="font-size:0.85rem;color:#374151;margin-bottom:6px"><strong>Mechanism:</strong> This is the system telling you the direction is still SHORT, but the information advantage is decaying: FDA posture and related regulatory moves are already spreading through Tier-1 outlets, which compresses timing edge even if the economic mechanism remains bearish for the sector. The bearish logic is simple: tighter or noisier FDA process tends to raise perceived compliance and approval risk, an</div><div style="font-size:0.85rem;color:#374151;margin-bottom:6px"><strong>Tripwire:</strong> It is INVESTIGATE rather than TRADE because the edge is explicitly “closing” and the propagation posture is catalytic. In a Mixed 62 regime with crosswind 72, late-entry macro shorts can get whipsawed unless you have a very clear next artefact (a new guidance, enforcement action, or concrete procedu</div><div style="font-size:0.85rem;color:#374151;margin-bottom:6px"><strong>Evidence:</strong> Upstream flags Tier-1 engagement (including Reuters/WSJ/NYT) as the key evidence of edge decay, but this cycle does not include specific URLs in the hydrated bundle for this item. Reference anchors for the underlying topic are the regulator domain and major wires: fda.gov and reuters.com.</div><div style="font-size:0.85rem;color:#b45309"><strong>Risks:</strong> whipsawed unless you have a very clear next artefact (a new guidance, enforcement action, or concrete procedural change) that restarts the clock.</div></div>
    <div style="background:#f0fdf4;border-radius:6px;padding:0.8rem 1rem;margin:0.8rem 0;font-size:0.85rem;border-left:3px solid #22c55e"><strong>&#128269; Watching For:</strong> I am looking for specific, definitive FDA actions or new guidelines that may serve as a solid catalyst to reaffirm the bearish narrative. Additionally, I want to see any shift in mainstream news coverage as a signal of further propagation.</div>
    <div style="background:#fff7ed;border-radius:6px;padding:0.8rem 1rem;margin:0.8rem 0;font-size:0.85rem;border-left:3px solid #f97316"><strong>&#9888; Concerns:</strong> I'm worried about the rapidly decaying edge quality and the potential for whipsawing if the market shifts quickly after I enter. The absence of strong regulatory signals means I need to be cautious.</div>
    <div style="margin:1.5rem 0"><div style="font-size:0.8rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:0.8rem;padding-bottom:4px;border-bottom:1px solid #e5e7eb">Private Narrative Log</div><div style="margin-bottom:1rem;padding:0.8rem 1rem;background:white;border-radius:6px;border-left:3px solid #d1d5db;box-shadow:0 1px 2px rgba(0,0,0,0.04)"><div style="font-size:0.85rem;color:#374151;line-height:1.6">The situation continues to evolve, but my conviction remains the same. The early signs of awareness within niche articles could point to an increasing focus on the FDA's regulatory landscape, but the absence of substantial news or guidelines is a clear limitation. I need to balance caution with the potential upside of entering the position at the right moment, knowing that the propagating narrative could change quickly. I am keenly observing for FDA insights that would reshape the current sentiment around compliance and approval risks.</div><div style="font-size:0.7rem;color:#9ca3af;margin-top:4px">Cycle 3 &middot; 2026-02-19T18:54</div></div><div style="margin-bottom:1rem;padding:0.8rem 1rem;background:white;border-radius:6px;border-left:3px solid #d1d5db;box-shadow:0 1px 2px rgba(0,0,0,0.04)"><div style="font-size:0.85rem;color:#374151;line-height:1.6">While the initial thesis of shorting IHE related to FDA regulation is still intact, the decay in edge quality combined with the current 'STIRRING' signal emphasizes a cautious stance. I need to see actions from the FDA that can reinvigorate the narrative and provide a robust basis for a short position. So far, the lack of mainstream coverage suggests that I'm still ahead of the market, but the clock is ticking, and I must tread carefully until I detect stronger confirmation of the thesis.</div><div style="font-size:0.7rem;color:#9ca3af;margin-top:4px">Cycle 2 &middot; 2026-02-19T17:51</div></div></div>
    <div style="margin:1.5rem 0"><div style="font-size:0.8rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:0.8rem;padding-bottom:4px;border-bottom:1px solid #e5e7eb">Due Diligence Log</div><div style="margin-bottom:0.8rem;padding:0.6rem 1rem;background:#f9fafb;border-radius:6px;border-left:3px solid #16a34a"><div style="display:flex;justify-content:space-between;align-items:center;margin-bottom:4px"><span style="font-weight:700;color:#16a34a">TRADE</span><span style="font-size:0.7rem;color:#9ca3af">pre_trade &middot; </span></div><div style="font-size:0.82rem;color:#374151">Fresh signal (3h), price stable (0.0% move), confidence 49%</div><div style="font-size:0.72rem;color:#6b7280;margin-top:3px">Price: $90.38 | Move: 0.0% | Staleness: 3h</div></div><div style="margin-bottom:0.8rem;padding:0.6rem 1rem;background:#f9fafb;border-radius:6px;border-left:3px solid #16a34a"><div style="display:flex;justify-content:space-between;align-items:center;margin-bottom:4px"><span style="font-weight:700;color:#16a34a">TRADE</span><span style="font-size:0.7rem;color:#9ca3af">watch_check &middot; </span></div><div style="font-size:0.82rem;color:#374151">Fresh signal (3h), price stable (0.0% move), confidence 49%</div><div style="font-size:0.72rem;color:#6b7280;margin-top:3px">Price: $90.38 | Move: 0.0% | Staleness: 3h</div></div></div>
    <div style="margin:1.5rem 0"><div style="font-size:0.8rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:0.8rem;padding-bottom:4px;border-bottom:1px solid #e5e7eb">Price History</div><div style="display:flex;flex-wrap:wrap;gap:6px"><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">14:21 $90.38 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">15:21 $90.38 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">16:21 $90.38 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">17:22 $90.38 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">18:22 $90.38 +0.0%</span></div></div>

    <div style="margin-top:2rem;padding-top:1rem;border-top:1px solid #e5e7eb;font-size:0.72rem;color:#9ca3af;text-align:center">
        Position #228 &middot; Updated 2026-02-19 18:56 UTC &middot; <a href="../" style="color:#9ca3af">Back to Trading Sheet</a>
    </div>
</div>
</body>
</html>